XML 20 R8.htm IDEA: XBRL DOCUMENT
v3.5.0.2

Condensed Consolidated Financial Statements Detail | 9 Months Ended
--- | ---
Sep. 30, 2016
Condensed Consolidated Financial Statements Detail [Abstract] |
Condensed Consolidated Financial Statements Detail | 3. Condensed Consolidated Financial Statements Detail Cash and Cash Equivalents As of September 30, 2016, cash and cash equivalents consisted of demand deposits of $4.1 million and money market funds of $16.5 million with maturities of less than 90 days at the date of purchase. As of December 31, 2015, cash and cash equivalents consisted of demand deposits of $23.2 million and money market funds of $42.6 million with maturities of less than 90 days at the date of purchase. Marketable Securities As of December 31, 2015, marketable securities of $0.5 million consisted of an investment in the common stock of a public entity. In August 2016, the Company sold all of its marketable securities and recognized a gain of $0.1 million in the Company’s condensed consolidated statements of comprehensive loss for the three and nine months ended September 30, 2016. Accordingly, as of September 30, 2016, the Company did not hold any marketable securities. Accrued and Other Liabilities Accrued and other liabilities consisted of the following (in thousands):
|  | September 30, |  |  | December 31, |
|  | 2016 |  |  | 2015 |
Accrued payroll and other benefits |  | $ | 1,682 |  |  | $ | 2,156 |
Deferred rent |  |  | 782 |  |  |  | 608 |
Accrued clinical trial costs |  |  | 669 |  |  |  | 406 |
Accrued incentive compensation |  |  | 569 |  |  |  | 2,609 |
Accrued legal and accounting fees |  |  | 389 |  |  |  | 517 |
Other |  |  | 723 |  |  |  | 729 |
Total |  | $ | 4,814 |  |  | $ | 7,025 |
Net Loss Per Share of Common Stock Potentially dilutive securities are excluded from the calculation of diluted net loss per share of common stock if their inclusion is anti-dilutive. The following table shows the weighted-average outstanding securities considered anti-dilutive and therefore excluded from the computation of diluted net loss per share of common stock (in thousands):
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2016 |  |  | 2015 |  |  | 2016 |  |  | 2015 |
Common stock options and RSUs |  |  | 558 |  |  |  | 548 |  |  |  | 549 |  |  |  | 481 |
Warrants for common stock |  |  | 917 |  |  |  | 908 |  |  |  | 915 |  |  |  | 908 |
Total |  |  | 1,475 |  |  |  | 1,456 |  |  |  | 1,464 |  |  |  | 1,389 |

X
- Definition The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement. + References No definition available. + Details
Name: | us-gaap_AdditionalFinancialInformationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Condensed Consolidated Financial Statements Detail [Abstract] + References No definition available. + Details
Name: | xoma_CondensedConsolidatedFinancialStatementsDetailAbstract
Namespace Prefix: | xoma_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration